Two consecutive cases of platinum-refractory pulmonary pleomorphic carcinoma that showed dramatic responses to MAID (mesna, doxorubicin, ifosfamide and dacarbazine) chemotherapy

Japanese Journal of Clinical Oncology

Volumn 41, Issue 3, 2011, Pages 430-433

  Lee, Keun Wook ^a   Kim, Yu Jung ^a   Kim, Jee Hyun ^a   Bang, Soo Mee ^a   Chung, Jin Haeng ^a   Lee, Jong Seok ^a  

^a Seoul National University Bundang Hospital   (South Korea)

Author keywords

Chemotherapy; Non small cell lung cancer; Pulmonary pleomorphic carcinoma

Indexed keywords

CISPLATIN; CYTOKERATIN; DACARBAZINE; DOCETAXEL; DOXORUBICIN; GEMCITABINE; IFOSFAMIDE; MESNA; PEMETREXED;

ADULT; ANEMIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER MORTALITY; CANCER PATIENT; CANCER REGRESSION; CANCER RESISTANCE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFICACY; DRUG RESPONSE; DRUG WITHDRAWAL; FATIGUE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEUKOPENIA; LUNG BIOPSY; LUNG CARCINOMA; LUNG PLEOMORPHIC CARCINOMA; MALE; MULTIPLE CYCLE TREATMENT; NEUTROPENIA; UNSPECIFIED SIDE EFFECT;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; DACARBAZINE; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; IFOSFAMIDE; LUNG NEOPLASMS; MALE; MESNA; MIDDLE AGED; ORGANOPLATINUM COMPOUNDS; SALVAGE THERAPY; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 79952403585     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyq180     Document Type: Article

References (7)

1. Beasley MB, Brambilla E, Travis WD. The 2004 World Health Organization classification of lung tumors. Semin Roentgenol 2005;40:90-7.
2. Brambilla E, Travis WD, Colby TV, Corrin B, Shimosato Y. The new World Health Organization classification of lung tumours. Eur Respir J 2001;18:1059-68.
3. Fishback NF, Travis WD, Moran CA, Guinee DG, Jr, McCarthy WF, Koss MN. Pleomorphic (spindle/giant cell) carcinoma of the lung. A clinicopathologic correlation of 78 cases. Cancer 1994;73: 2936-45.
4. Bae HM, Min HS, Lee SH, Kim DW, Chung DH, Lee JS, et al. Palliative chemotherapy for pulmonary pleomorphic carcinoma. Lung Cancer 2007;58:112-5.
5. Hong JY, Choi MK, Uhm JE, Park MJ, Lee J, Park YH, et al. The role of palliative chemotherapy for advanced pulmonary pleomorphic carcinoma. Med Oncol 2009;26:287-91.
6. Elias A, Ryan L, Sulkes A, Collins J, Aisner J, Antman KH. Response to mesna, doxorubicin, ifosfamide, and dacarbazine in 108 patients with metastatic or unresectable sarcoma and no prior chemotherapy. J Clin Oncol 1989;7:1208-16.
7. Antman K, Crowley J, Balcerzak SP, Rivkin SE, Weiss GR, Elias A, et al. An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas. J Clin Oncol 1993;11:1276-85.